Biggest News Aggregation in the World
📰 Acticor Biotech News

Page 4 - Acticor Biotech News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Acticor Biotech. Real-time updates on events, politics, business and more.

World's first clinical trial to test new drug glenzocimab for heart attacks

A potential new drug to improve the long-term outcomes for heart attack patients will be trialled in the UK. With the signing of a partnership between the University of Birmingham and Acticor Biotech, a new clinical trial called LIBERATE will take place in two acute care hospitals in the UK: the Queen Elizabeth ...
United Kingdom Mark Thomas Gilles Avenard Jon Townend Institute Of Cardiovascular Sciences Consultant Cardiologist At University Hospitals Birmingham

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Acticor Biotech: World's First Clinical Trial to Test New Drug Glenzocimab for Heart Attacks Seite 1

22.11.2022 - Regulatory News: Partnership between the University of Birmingham and Acticor Biotech (Paris:ALACT) will see patients with heart attacks treated with glenzocimab, a promising new class of drug for the first time. A potential new drug to improve the ... Seite 1
United Kingdom Institute Of Cardiovascular Sciences University Of Birmingham University Hospitals Birmingham Acticor Biotech Elizabeth Hospital

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science